Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders-Reference-Cited by-同舟云学术

Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders

Published:2021-03-02 Issue:4 Volume:27 Page:515-518
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Kaczmarek Radoslaw¹^ORCID,El Ekiaby Magdy¹²,Hart Daniel P.¹³⁴,Hermans Cedric¹⁵,Makris Mike¹⁶^ORCID,Noone Declan¹⁷,O’Mahony Brian¹⁸⁹^ORCID,Page David¹¹⁰^ORCID,Peyvandi Flora¹¹¹¹²^ORCID,Pipe Steven W.¹¹³¹⁴^ORCID,Sannié Thomas¹⁷¹⁵^ORCID,Schlenkrich Uwe¹¹⁶,Skinner Mark W.¹¹⁷¹⁸^ORCID,Srivastava Alok¹¹⁹^ORCID,Bok Amanda⁷,Pierce Glenn F.¹²⁰^ORCID,

Affiliation:

1. Coagulation Product Safety, Supply and Access Committee World Federation of Hemophilia Montreal Quebec Canada

2. Shabrawishi Hospital Blood Transfusion & Hemophilia Treatment Center Giza Egypt

3. The Royal London Hospital Haemophilia CentreBarts Health NHS Trust London UK

4. Centre for Immunobiology Blizard InstituteBarts and The London School of Medicine and DentistryQMUL London UK

5. Hemostasis and Thrombosis Unit Division of Hematology Cliniques Universitaires Saint‐LucUCLouvain Brussels Belgium

6. Medical Advisory Group European Haemophilia Consortium Brussels Belgium

7. European Haemophilia Consortium Brussels Belgium

8. Irish Haemophilia Society Dublin Ireland

9. Trinity College Dublin Ireland

10. Canadian Hemophilia Society Montreal Canada

11. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan Italy

12. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy

13. Medical and Scientific Advisory Council National Hemophilia Foundation New York NY USA

14. Departments of Pediatrics and Pathology University of Michigan Ann Arbor MI USA

15. Association Française des Hémophiles Paris France

16. German Haemophilia Society Hamburg Germany

17. Institute for Policy Advancement Ltd Washington DC USA

18. McMaster University Hamilton Ontario Canada

19. Department of Haematology Christian Medical College Vellore India

20. World Federation of Hemophilia Montreal Quebec Canada

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14271

Reference18 articles.

1. Three decades of messenger RNA vaccine development

2. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

3. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

5. Moderna’s COVID‐19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna Inc.https://investors.modernatx.com/news‐releases/news‐release‐details/modernas‐covid‐19‐vaccine‐candidate‐meets‐i

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry;Haemophilia;2024-06-06

2. Sars-CoV-2 infection in different hematological patients;Management, Body Systems, and Case Studies in COVID-19;2024

3. Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study;Journal of Clinical Medicine;2023-08-23

4. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs;Food and Chemical Toxicology;2022-06

5. Short-time Safety of the Sinopharm COVID-19 Vaccine in Patients with Hemophilia;Archives of Clinical Infectious Diseases;2022-05-30